Category: ROOT

Viatris acquires 2 ophthalmology companies, plans to add $1B in sales

Healthcare company Viatris has acquired Oyster Point Pharma and Famy Life Sciences as part of its plan to create an ophthalmology franchise. 

Pharmacist shortage could exacerbate low flu vaccination rates

Since the beginning of the COVID-19 pandemic, flu vaccination rates have slowed — a trend that could be worsened by the nation’s pharmacy workforce issue. 

10 hospitals seeking chief medical officers

Below are 10 hospitals, health systems or hospital operators that posted job listings seeking chief medical officers in the last two weeks.

COVID-19 cases to jump 39% by Nov. 17, Mayo forecasts

COVID-19 cases are projected to increase by nearly 40 percent over the next two weeks, though it’s still unclear whether hospitalizations and deaths may follow suit in November, according to national disease modeling. 

Atlantic Health opens 75,000-square-foot ASC

Morristown, N.J.-based Atlantic Health System has opened a 75,000-square-foot ASC at its Morristown Medical Center Health Pavilion in Rockaway, N.J., according to a Nov. 7 report from NJBiz. 

6 drugmakers short on flu drug

As hospitals tackle an early flu season with viral infections soaring, six drugmakers have reported short supply of oseltamivir, a common flu drug. 

Vanderbilt hospital boots investment chief, takes assets to Morgan Stanley

Nashville, Tenn.-based Vanderbilt University Medical Center has ousted its chief investment officer and passed the baton to Morgan Stanley, Chief Investment Officer reported Nov. 3. 

New York community hospital begins construction on $15M cancer center

Auburn (N.Y.) Community Hospital will begin construction on its $15 million cancer center Nov. 7, auburnpub.com reported.

UPMC partners with physician to offer cancer services in Croatia

Pittsburgh-based UPMC is partnering with Dragan Primorac, MD, PhD, a physician and professor in Croatia, to open the first of many cancer centers in the country.

Paxlovid cuts long COVID-19 risk, early VA findings show

People who take the antiviral Paxlovid within the first few days of a COVID-19 infection may have a 25 percent lower risk of developing a number of conditions associated with long COVID-19, according to findings published Nov. 5 in the preprint server …